Pneumococcal sialidase promotes bacterial survival by fine-tuning of pneumolysin-mediated membrane disruption
Cell Reports · 2024-03 · 43 (3) · 113962
DOI: 10.1016/j.celrep.2024.113962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-03. Verfasst von Sayaka Shizukuishi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan; Department of Microbiology, Yokohama City University Graduate …. Hauptthemen laut MEDLINE: Neuraminidase, Pneumococcal Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Naito Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Pneumolysin (Ply) is an indispensable cholesterol-dependent cytolysin for pneumococcal infection. Although Ply-induced disruption of pneumococci-containing endosomal vesicles is a prerequisite for the evasion of endolysosomal bacterial clearance, its potent activity can be a double-edged sword, having a detrimental effect on bacterial survivability by inducing severe endosomal disruption, bactericidal autophagy, and scaffold epithelial cell death. Thus, Ply activity must be maintained at optimal levels. We develop a highly sensitive assay to monitor endosomal disruption using NanoBiT-Nanobody, which shows that the pneumococcal sialidase NanA can fine-tune Ply activity by trimming sialic acid from cell-membrane-bound glycans. In addition, oseltamivir, an influenza A virus sialidase inhibitor, promotes Ply-induced endosomal disruption and cytotoxicity by inhibiting NanA activity in vitro and greater tissue damage and bacterial clearance in vivo. Our findings provide a foundation for innovative therapeutic strategies for severe pneumococcal infections by exploiting the duality of Ply activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan; Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
- Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan. Electronic address: micogawa@niid.go.jp.
- Department of Transformative Infection Control Development Studies, Osaka University Graduate School of Medicine, Osaka, Japan; Division of Fostering Required Medical Human Resources, Center for Infectious Disease Educa…
- Division of Fostering Required Medical Human Resources, Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan; Department of Transformative Analysis for Human Specimen, Osaka Unive…
- Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
- Laboratory of Morphology and Image Analysis, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Cellular and Molecular Neuropathology, Research Institute fo…
Förderung
- Naito Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Shizukuishi, S., Ogawa, M., Kuroda, E., Hamaguchi, S., Sakuma, C., Kakuta, S., Tanida, I., Uchiyama, Y., Akeda, Y., Ryo, A., & Ohnishi, M. (2024). Pneumococcal sialidase promotes bacterial survival by fine-tuning of pneumolysin-mediated membrane disruption. Cell Reports, 43(3), 113962. https://doi.org/10.1016/j.celrep.2024.113962
Vancouver
Shizukuishi S, Ogawa M, Kuroda E, Hamaguchi S, Sakuma C, Kakuta S, et al. Pneumococcal sialidase promotes bacterial survival by fine-tuning of pneumolysin-mediated membrane disruption. Cell Reports. 2024;43(3):113962. doi:10.1016/j.celrep.2024.113962
BibTeX
@article{Shizukuishi2024,
author = {Shizukuishi, Sayaka and Ogawa, Michinaga and Kuroda, Eisuke and Hamaguchi, Shigeto and Sakuma, Chisato and Kakuta, Soichiro and Tanida, Isei and Uchiyama, Yasuo and Akeda, Yukihiro and Ryo, Akihide and Ohnishi, Makoto},
title = {Pneumococcal sialidase promotes bacterial survival by fine-tuning of pneumolysin-mediated membrane disruption},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {3},
pages = {113962},
doi = {10.1016/j.celrep.2024.113962}
}
EUVIMED